Host‐iron assimilation: pathogenesis and novel therapies of mucormycosis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Mycoses (Berlin)

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/myc.12232PMID 25178879PMCID PMC4461208
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infectious disease.

  2015cited by this paper
• CotH3 mediates fungal invasion of host cells during mucormycosis.

  2014cited by this paper
• Mucormycosis in a Patient with Acute Myeloid Leukemia Successfully Treated with Liposomal Amphotericin B Associated with Deferasirox and Hyperbaric Oxygen

  2013cited by this paper
• Deferasirox as adjunctive therapy for mucormycosis.

  2012cited by this paper
• Invasive mold infections following combat-related injuries.

  2012cited by this paper
• Meeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on Mucormycosis.

  2012cited by this paper
• Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011.

  2012cited by this paper
• Deferasirox in mucormycosis: hopefully, not defeated.

  2012cited by this paper
• Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species

  2011cited by this paper
• Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.

  2011cited by this paper
• Mucormycosis and Entomophthoramycosis (Zygomycosis)

  2011cited by this paper
• The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.

  2011cited by this paper
• Host cell invasion in mucormycosis: role of iron.

  2011cited by this paper
• The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis

  2010cited by this paper
• The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.

  2010cited by this paper
• Apophysomyces elegans: Epidemiology, Amplified Fragment Length Polymorphism Typing, and In Vitro Antifungal Susceptibility Pattern

  2010cited by this paper
• Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis

  2009cited by this paper
• Fatal Actinomucor elegans var. kuwaitiensis Infection following Combat Trauma

  2009cited by this paper
• Invasive zygomycosis in India: experience in a tertiary care hospital

  2009cited by this paper
• Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006

  2009cited by this paper
• Overview of opportunistic fungal infections in India.

  2008cited by this paper
• Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis

  2008cited by this paper
• GRP78 induction in cancer: therapeutic and prognostic implications.

  2007cited by this paper
• ER chaperones in mammalian development and human diseases

  2007cited by this paper
• The iron chelator deferasirox protects mice from mucormycosis through iron starvation.

  2007cited by this paper
• Stress induction of GRP78/BiP and its role in cancer.

  2006cited by this paper
• Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management.

  2006cited by this paper
• Deferiprone iron chelation as a novel therapy for experimental mucormycosis.

  2006cited by this paper
• Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

  2005cited by this paper
• Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka.

  2005cited by this paper
• Rhizopus oryzae Adheres to, Is Phagocytosed by, and Damages Endothelial Cells In Vitro

  2005cited by this paper
• Zygomycosis (mucormycosis): emerging clinical importance and new treatments

  2004cited by this paper
• Apophysomyces elegans: an Emerging Zygomycete in India

  2003cited by this paper
• Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

  2003cited by this paper
• Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

  2002cited by this paper
• Interscience Conference on Antimicrobial Agents and Chemotherapy

  2001cited by this paper
• Zygomycetes in human disease.

  2000cited by this paper
• Zygomycosis in the 1990s in a tertiary-care cancer center.

  2000cited by this paper
• Acquisition, Transport, and Storage of Iron by Pathogenic Fungi

  1999cited by this paper
• A Permease-Oxidase Complex Involved in High-Affinity Iron Uptake in Yeast

  1996cited by this paper
• Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components.

  1996cited by this paper
• Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect.

  1994cited by this paper
• Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus.

  1994cited by this paper
• Mucormycosis (zygomycosis): is there news for the clinician?

  1994cited by this paper
• Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

  1993cited by this paper
• Agents of mucormycosis and related species.

  1990cited by this paper
• The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature.

  1988cited by this paper
• Mucormycosis infection in dialysis patients.

  1987cited by this paper
• A Mechanism of Susceptibility to Mucormycosis in Diabetic Ketoacidosis Transferrin and Iron Availability

  1982cited by this paper
• Principles and practice of infectious diseases. Vols 1 and 2.

  1979cited by this paper

• COVID-19 associated mucormycosis and their therapeutics

  2026cites this paper
• Transcriptomic and proteomic profiling of pulmonary mucormycosis reveals a failed activation of host immune response.

  2026cites this paper
• Virulence and pathogenicity of secondary fungal infections

  2026cites this paper
• Role of the putative sit1 gene in normal germination of spores and virulence of the Mucor lusitanicus

  2025cites this paper
• Key fungal coinfections: epidemiology, mechanisms of pathogenesis, and beyond

  2025cites this paper
• Epidemiology, pathogenesis, clinical characteristics, and treatment of mucormycosis: a review

  2024cites this paper
• Corticosteroid therapy associated with Covid-19: an ally or a risk factor for the establishment of secondary fungal co-infections?

  2023cites this paper
• Mucormycosis—A significant hazard in the COVID-19 pandemic?

  2023cites this paper
• Mucormycosis in 2023: an update on pathogenesis and management

  2023cites this paper
• The hospitalization rate and clinical characteristics of mucormycosis prior and during COVID-19 pandemic: A single-center study.

  2023cites this paper
• COVID-19-associated mucormycosis in India: Why such an outbreak?

  2023cites this paper
• Mouse Models of Mucormycosis.

  2023cites this paper
• Mucormycosis, past and present: a comprehensive review.

  2023cites this paper
• COVID-19 associated mucormycosis – An emerging threat

  2022cites this paper
• Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives

  2022cites this paper
• Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period.

  2022cites this paper
• Identification of novel inhibitors of high affinity iron permease (FTR1) through implementing pharmacokinetics index to fight against black fungus: An in silico approach.

  2022cites this paper
• Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19

  2022cites this paper
• A closer look at pathogenesis of cerebral mucormycosis in diabetic condition: A mini review

  2021cites this paper
• Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients

  2021cites this paper
• Serum iron indices in COVID‐19‐associated mucormycosis: A case–control study

  2021cites this paper
• Mucormycoses

  2021cites this paper
• Human albumin enhances the pathogenic potential of Candida glabrata on vaginal epithelial cells

  2021cites this paper
• Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World

  2021cites this paper
• Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review.

  2021cites this paper
• Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient

  2021cites this paper
• [Mucormycosis: Current and future management perspective].

  2021cites this paper
• Disseminated Pulmonary Mucormycosis Involving the Jejunum in an Acute Lymphoblastic Leukemia Patient

  2020cites this paper
• Iron Assimilation during Emerging Infections Caused by Opportunistic Fungi with emphasis on Mucorales and the Development of Antifungal Resistance

  2020cites this paper
• Mucormycosis in a 40-year-old woman with diabetic ketoacidosis

  2020cites this paper
• Mucormycosis

  2020cites this paper
• Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients

  2019cites this paper
• Animal Models to Study Mucormycosis

  2019cites this paper
• Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature

  2018cites this paper
• Rhinocerebral mucormycosis, risk factors and the type of oral manifestations in patients referred to a University Hospital in Tabriz, Iran 2007‐2017

  2018cites this paper
• Deferiprone as adjunctive treatment for patients with invasive mucormycosis: A retrospective case series

  2018cites this paper